Tag: PE
-
YAZ / Yasmin / Ocella / Gianvi Blood Clot Lawsuits That Are Not Settled Yet: Number Increases, Indicating That These Legal Claims Continue To Be Filed In 2013
Bayer Has Paid $1.4 Billion In Settlements for Cases Involving Deep Vein Thrombosis (DVT) And/Or Pulmonary Embolism (PE), Also Called "Venous Clot Injuries" (Posted by Tom Lamb at DrugInjuryWatch.com)Previously, we reported that more than…
-
Summer 2013 Bayer Lawsuits Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits Continue To Be Settled, With New Cases Being Filed
Bayer Financial Report Shows That More Than 2,500 Venous / Blood Clot Cases (DVT and/or PE) Do Not Have Settlement Agreements As Of April 15, 2013 (Posted by Tom Lamb at DrugInjuryWatch.com)From the "Product-related litigations"…
-
Some Newer Contraceptive Methods Such As NuvaRing And YAZ / Yasmin Are Under Increasing Scrutiny Over In Europe
Is The FDA Doing Enough About Birth Control Products That Contain Third Generation Or Fourth Generation Progestins And Are Associated With Higher Risks Of Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) A January 3,…
-
November 2012 Litigation And Settlements Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits
Bayer Has Settled Less Than Half The DVT And PE Blood Clot Claims Filed Or Cases Subject To Tolling Agreements (Posted by Tom Lamb at DrugInjuryWatch.com) In late October 2012 we received the Bayer Stockholders’ Newsletter…
-
Disturbing Information About NuvaRing Safety Found In Motions On Experts Recently Unsealed By Federal Court MDL Judge
Newly Available Expert Analysis Of Confidential Drug Company Data Reveals That NuvaRing Estrogen Levels In Studies Were A Cause For Concern, And The Method Of Reporting Was Misleading (Posted by Tom Lamb at DrugInjuryWatch.com)…
-
2012 FDA Report On Beyaz Points Out That Younger Women and Girls Are Most At-Risk For Blood Clots
Approved By FDA In 2010, There Has Been No Study Done Yet Regarding Beyaz Safety — Despite Significant Number Of Beyaz Adverse Event Reports (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: FDA Meeting…
-
Bayer Settlements: Gianvi / Ocella / Yasmin / YAZ: July 2012 Update On Drug Injury Lawsuits Filed To Date
Almost 2,000 Lawsuits With Blood Clots Such As DVT And PE Settled, With At Least Another 4,000 Such Cases In Settlement Mediation Negotiations (Posted by Tom Lamb at DrugInjuryWatch.com) From Bayer's Stockholders' Newsletter Second…
-
Merck’s NuvaRing Increases The Relative Risk For Blood-Clot Side Effects Says Medical Expert After Weighing Competing Studies
And Another Medical Journal Article Concludes Venous Thromboembolism (VTE) Risk Associated With NuvaRing Is As High As YAZ Or Yasmin And Ortho Evra (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2012 I wrote…